Catalyst
Slingshot members are tracking this event:
Opko study of its CTAP101 capsules in treating patients with bone metastases caused by breast or prostate cancer set for December 2018 completion date
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| OPK |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 27, 2019
Occurred Source:
https://clinicaltrials.gov/ct2/history/NCT02274623?V_14=View#StudyPageTop
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Metastatic Breast Cancer, Metastatic Prostate Cancer
